We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Medicinal signaling cell (1)
- MSC cell therapy
- Sensors & switchers of inflammation
- MSCs are released when a blood vessel breaks
- MSC therapy for neuropathic pain
- MSC therapy for neuropathic pain: animal model
- Pain management
- MSC-based therapies
- Phagocytosis of the hMSCs by monocytic cells
- MSC-instructed monocytes
- Regulatory T cell generation
- Long-term benefits of hMSCs
- Innate MSC functions
- MSCs: immunomodulation
- Medicinal signaling cell (2)
- Fat tissue and MSCs
- Tissue-specific immune properties of MSCs
- Fat vasculature
- Identification of a mesenchymal progenitor cell hierarchy in adipose tissue
- Multi-site MSC-based therapies
- PDGF-BB and PRP
- MSCs: nature’s drugstores
- MSCs: summary
- MSCs manage your regenerative potential
- Cell-based therapy: where are we?
- Acknowledgments
Topics Covered
- Medicinal signaling cells
- Pain management
- MSC-based therapies
- Mesenchymal Stem Cells (MSCs)
- MSC-instructed monocytes
- Long-term benefits of hMSCs
- MSCs and immunomodulation
- Adipose tissue and MSCs
- Innate MSC function
- PDGF-BB and PRP
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Caplan, A.I. (2025, November 30). Bone marrow mesenchymal cells 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 1, 2025, from https://doi.org/10.69645/YYXZ8910.Export Citation (RIS)
Publication History
- Published on November 30, 2025
Financial Disclosures
- Professor Caplan was the former Officer and Founder of Osiris Therapeutics, Inc which receives funding from Mesoblast Ltd. Royalties are shared between Case Western University and Prof. Caplan. Professor Caplan also provided a consulting service to many individuals and organisations globally within the regenerative medicine space.
Bone marrow mesenchymal cells 2
Published on November 30, 2025
29 min
Other Talks in the Series: Periodic Reports: Advances in Clinical Interventions and Research Platforms
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, there, my name
is Arnold Caplan.
I'm a professor of biology at
Case Western Reserve University,
as it says on this slide.
I've been asked to talk about
bone marrow mesenchymal cells.
0:19
I make the point that
MSCs are not stem cells.
They're drug stores for
injury-specific tissues.
Very different concept
than a stem cell.
0:34
I'll talk about the
therapeutic concepts for
how MSCs work at different
locations in your body.
First of all, the
MSCs themselves have
a response profile which
is genetically wired
into these cells.
0:56
This older paper
shows the blue MSCs.
If you give it information
that shows that
it's an inflammatory
microenvironment,
they make anti-inflammatory
drugs and
cell surface receptors.
If you give it signals
on the right-hand side—
that there are bacteria around,
it makes inflammatory cytokines.
Those inflammatory
cytokines bring cells from
the hematopoietic system
into that site to
eat up all those pesky bacteria.
Here's the same cell,
two different sets of sensors,
two different sets of stimuli,
two different hardwire
responses which
I call immunomodulatory.